SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,883,200 | -9.5% | 560,000 | -14.5% | 0.15% | -5.5% |
| Q2 2023 | $75,010,600 | +35.9% | 655,000 | +63.6% | 0.16% | +31.5% |
| Q1 2023 | $55,180,241 | -36.9% | 400,350 | -40.7% | 0.12% | -40.7% |
| Q4 2022 | $87,466,500 | -10.6% | 675,000 | -23.7% | 0.21% | -14.0% |
| Q3 2022 | $97,828,000 | +3.2% | 885,000 | -30.0% | 0.24% | +12.0% |
| Q2 2022 | $94,824,000 | +19.6% | 1,265,000 | +24.6% | 0.22% | +43.7% |
| Q1 2022 | $79,292,000 | +35.5% | 1,015,000 | +56.2% | 0.15% | +43.8% |
| Q4 2021 | $58,533,000 | +58.2% | 650,000 | +62.5% | 0.10% | +43.8% |
| Q3 2021 | $36,992,000 | +32.3% | 400,000 | +11.2% | 0.07% | +32.7% |
| Q2 2021 | $27,967,000 | -45.3% | 359,753 | +19.9% | 0.06% | -50.9% |
| Q4 2020 | $51,147,000 | -57.2% | 300,000 | -64.7% | 0.11% | -62.5% |
| Q3 2020 | $119,366,000 | -32.3% | 850,000 | -22.7% | 0.30% | -33.8% |
| Q2 2020 | $176,374,000 | -11.0% | 1,100,000 | -45.7% | 0.45% | -23.6% |
| Q1 2020 | $198,086,000 | +41.2% | 2,025,000 | +86.2% | 0.59% | +71.6% |
| Q4 2019 | $140,309,000 | +8.0% | 1,087,330 | -37.0% | 0.34% | +8.2% |
| Q3 2019 | $129,924,000 | -28.7% | 1,724,956 | +43.7% | 0.32% | -29.7% |
| Q2 2019 | $182,340,000 | -7.3% | 1,200,000 | -27.3% | 0.45% | -7.7% |
| Q1 2019 | $196,664,000 | -23.3% | 1,650,000 | -29.8% | 0.49% | -30.8% |
| Q4 2018 | $256,471,000 | +22.2% | 2,350,144 | +80.8% | 0.71% | +51.9% |
| Q3 2018 | $209,963,000 | +50.3% | 1,300,000 | +23.0% | 0.47% | +46.2% |
| Q2 2018 | $139,663,000 | +1785.0% | 1,056,611 | +956.6% | 0.32% | +1782.4% |
| Q1 2018 | $7,409,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |